Table 2

Comparative analysis of treatment patterns

 ConcordancePartial concordanceDiscordance 
Age (years), mean (s.d.)67.8 (12.1)70.4 (11.6)77.6 (13)F(2,95) = 4.47, P = 0.014
Concordance-discordance, P = 0.011
Cancer type (C18-C21)X2(4) = 9.89, P = 0.042
 C18 (0–8)43 (60.6)1 (10.0)9 (52.9)
 C194 (5.6)1 (10.0)2 (11.8)
 C2024 (33.8)8 (80.0)6 (35.3)
ASA scoreX2(4) = 22.31, P < 0.001
 II40 (56.3)5 (50.0)4 (23.5)
 III31 (43.7)5 (50.0)9 (53.0)
 IV0 (0.0)0 (0.0)4 (23.5)
Tumour T stageX2(8) = 4.62, P = 0.798
 06 (9.2)0 (0.0)0 (0.0)
 18 (12.3)2 (22.2)3 (17.6)
 212 (18.5)2 (22.2)4 (23.5)
 330 (46.2)4 (44.5)6 (35.4)
 49 (13.8)1 (11.1)4 (23.5)
Lymph node N stageX2(4) = 9.63, P = 0.047
 050 (76.9)3 (37.5)14 (82.4)
 18 (12.3)4 (50.0)3 (17.6)
 27 (10.8)1 (12.5)0 (0.0)
 ConcordancePartial concordanceDiscordance 
Age (years), mean (s.d.)67.8 (12.1)70.4 (11.6)77.6 (13)F(2,95) = 4.47, P = 0.014
Concordance-discordance, P = 0.011
Cancer type (C18-C21)X2(4) = 9.89, P = 0.042
 C18 (0–8)43 (60.6)1 (10.0)9 (52.9)
 C194 (5.6)1 (10.0)2 (11.8)
 C2024 (33.8)8 (80.0)6 (35.3)
ASA scoreX2(4) = 22.31, P < 0.001
 II40 (56.3)5 (50.0)4 (23.5)
 III31 (43.7)5 (50.0)9 (53.0)
 IV0 (0.0)0 (0.0)4 (23.5)
Tumour T stageX2(8) = 4.62, P = 0.798
 06 (9.2)0 (0.0)0 (0.0)
 18 (12.3)2 (22.2)3 (17.6)
 212 (18.5)2 (22.2)4 (23.5)
 330 (46.2)4 (44.5)6 (35.4)
 49 (13.8)1 (11.1)4 (23.5)
Lymph node N stageX2(4) = 9.63, P = 0.047
 050 (76.9)3 (37.5)14 (82.4)
 18 (12.3)4 (50.0)3 (17.6)
 27 (10.8)1 (12.5)0 (0.0)

Values are n (%) unless otherwise stated. Subgroup analysis of the treatment recommendations of ChatGPT of multidisciplinary team 1 by category. Statistically significant P-values are highlighted in bold. ASA, American Society of Anesthesiologists.

Table 2

Comparative analysis of treatment patterns

 ConcordancePartial concordanceDiscordance 
Age (years), mean (s.d.)67.8 (12.1)70.4 (11.6)77.6 (13)F(2,95) = 4.47, P = 0.014
Concordance-discordance, P = 0.011
Cancer type (C18-C21)X2(4) = 9.89, P = 0.042
 C18 (0–8)43 (60.6)1 (10.0)9 (52.9)
 C194 (5.6)1 (10.0)2 (11.8)
 C2024 (33.8)8 (80.0)6 (35.3)
ASA scoreX2(4) = 22.31, P < 0.001
 II40 (56.3)5 (50.0)4 (23.5)
 III31 (43.7)5 (50.0)9 (53.0)
 IV0 (0.0)0 (0.0)4 (23.5)
Tumour T stageX2(8) = 4.62, P = 0.798
 06 (9.2)0 (0.0)0 (0.0)
 18 (12.3)2 (22.2)3 (17.6)
 212 (18.5)2 (22.2)4 (23.5)
 330 (46.2)4 (44.5)6 (35.4)
 49 (13.8)1 (11.1)4 (23.5)
Lymph node N stageX2(4) = 9.63, P = 0.047
 050 (76.9)3 (37.5)14 (82.4)
 18 (12.3)4 (50.0)3 (17.6)
 27 (10.8)1 (12.5)0 (0.0)
 ConcordancePartial concordanceDiscordance 
Age (years), mean (s.d.)67.8 (12.1)70.4 (11.6)77.6 (13)F(2,95) = 4.47, P = 0.014
Concordance-discordance, P = 0.011
Cancer type (C18-C21)X2(4) = 9.89, P = 0.042
 C18 (0–8)43 (60.6)1 (10.0)9 (52.9)
 C194 (5.6)1 (10.0)2 (11.8)
 C2024 (33.8)8 (80.0)6 (35.3)
ASA scoreX2(4) = 22.31, P < 0.001
 II40 (56.3)5 (50.0)4 (23.5)
 III31 (43.7)5 (50.0)9 (53.0)
 IV0 (0.0)0 (0.0)4 (23.5)
Tumour T stageX2(8) = 4.62, P = 0.798
 06 (9.2)0 (0.0)0 (0.0)
 18 (12.3)2 (22.2)3 (17.6)
 212 (18.5)2 (22.2)4 (23.5)
 330 (46.2)4 (44.5)6 (35.4)
 49 (13.8)1 (11.1)4 (23.5)
Lymph node N stageX2(4) = 9.63, P = 0.047
 050 (76.9)3 (37.5)14 (82.4)
 18 (12.3)4 (50.0)3 (17.6)
 27 (10.8)1 (12.5)0 (0.0)

Values are n (%) unless otherwise stated. Subgroup analysis of the treatment recommendations of ChatGPT of multidisciplinary team 1 by category. Statistically significant P-values are highlighted in bold. ASA, American Society of Anesthesiologists.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close